Author

R. Borrow

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Dowell· 1 shared A. Horsley· 1 shared B. Hallis· 1 shared B. Parker· 1 shared C.P.C. Gowda· 1 shared E. A. McKenzie· 1 shared E. Linley· 1 shared F. Aiano· 1 shared

Activity by Year

2017-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Dowell

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection

J. Zuo, A. Dowell, H. Pearce, K. Verma, H. Long, J. Begum, F. Aiano, Z. Amin-Chowdhury, B. Hallis, L. Stapley, R. Borrow, E. Linley, S. Ahmad, B. Parker, A. Horsley, , P. Moss

This study shows that SARS-CoV-2-specific T-cell immunity remains robust six months after infection, with response magnitude linked to initial infection severity.

bioRxiv · Nov 1, 2020Immunology

A novel strategy to express different antigens from one modified vaccinia Ankara vaccine vector

K. B. Lauer, E. A. McKenzie, Y. Hall, C.P.C. Gowda, P. Klapper, R. Borrow, P.J. Vallely, M. W. Carroll, T. J. Blanchard

The paper develops a modified Vaccinia Ankara vector expressing antigens from multiple pathogens and tests its immunogenicity in mice, finding that while MVA-specific antibodies were induced, no antibodies against RABV or HBV were detected.

bioRxiv · Sep 21, 2017 · PreprintImmunology